Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic
  2. Cotton, L. A.; Kuang, X. T.; Le, A. Q.; Carlson, J. M.; Chan, B.; Chopera, D. R.; Brumme, C. J.; Markle, T. J.; Martin, E.; Shahid, A.; Anmole, G.; Mwimanzi, P.; Nassab, P.; Penney, K. A.; Rahman, M. A.; Milloy, M. J.; Schechter, M. T.; Markowitz, M.; Carrington, M.; Walker, B. D.; Wagner, T.; Buchbinder, S.; Fuchs, J.; Koblin, B.; Mayer, K. H.; Harrigan, P. R.; Brockman, M. A.; Poon, A. F.; Brumme, Z. L.
  3. Plos Genetics. 2014, Apr; 10(4): e1004295.
  1. 2.   MPGAfold in dengue secondary structure prediction
  2. Kasprzak, W. K.; Shapiro, B. A.
  3. Methods in molecular biology (Clifton, N.J.). 2014, 20-Feb; 1138: 199-224.
  1. 3.   Structure of the Taz2 domain of p300: insights into ligand binding
  2. Miller, M.; Dauter, Z.; Cherry, S.; Tropea, J. E.; Wlodawer, A.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Dec; 65(Pt 12): 1301-8.
  1. 4.   Overproduction, purification and structure determination of human dual-specificity phosphatase 14
  2. Lountos, G. T.; Tropea, J. E.; Cherry, S.; Waugh, D. S.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Oct; 65(Pt 10): 1013-20.
  1. 5.   Virus maturation as a new HIV-1 therapeutic target
  2. Adamson, C. S.; Salzwedel, K.; Freed, E. O.
  3. Expert opinion on therapeutic targets. 2009, Aug; 13(8): 895-908.
  1. 6.   Signaling dynamics of the KSR1 scaffold complex
  2. McKay, M. M.; Ritt, D. A.; Morrison, D. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009, Jul 7; 106(27): 11022-7.
  1. 7.   Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78
  2. Das, R.; Mariano, J.; Tsai, Y. C.; Kalathur, R. C.; Kostova, Z.; Li, J.; Tarasov, S. G.; McFeeters, R. L.; Altieri, A. S.; Ji, X.; Byrd, R. A.; Weissman, A. M.
  3. Molecular Cell. 2009, Jun 26; 34(6): 674-85.
  1. 8.   Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle
  2. Pasek, M.; Ramakrishnan, B.; Boeggeman, E.; Manzoni, M.; Waybright, T. J.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2009, Mar 18; 20(3): 608-18.
  1. 9.   Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor
  2. Zhang, M. Y.; Feng, Y.; Wang, Y.; Dimitrov, D. S.
  3. Mabs. 2009, Sep-Oct; 1(5): 475-80.
  1. 10.   HIV-1 RNA dimerization: It takes two to tango
  2. Moore, M. D.; Hu, W. S.
  3. Aids Reviews. 2009 11(2): 91-102.
  1. 11.   Organizing, exploring, and analyzing antibody sequence data: the case for relational-database managers
  2. Owens, J.
  3. Methods in molecular biology (Clifton, N.J.). 2009 525: 569-80, xiv.
  1. 12.   Gene targeting in mouse embryonic stem cells
  2. Tessarollo, L.; Palko, M. E.; Akagi, K.; Coppola, V.
  3. Methods in molecular biology (Clifton, N.J.). 2009 530: 141-164.
  1. 13.   Genetic characterization of feline leukemia virus from Florida panthers
  2. Brown, M. A.; Cunningham, M. W.; Roca, A. L.; Troyer, J. L.; Johnson, W. E.; O'Brien, S. J.
  3. Emerging Infectious Diseases. 2008 14(2): 252-259.
  1. 14.   High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides
  2. Ellis, H. M.; Yu, D.; DiTizio, T.; Court, D. L.
  3. Proceedings of the National Academy of Sciences U S A. 2001 98(12): 6742-6746.
  1. 15.   Structure of the N-terminal domain of Yersinia pestis YopH at 2.0 A resolution
  2. Evdokimov, A. G.; Tropea, J. E.; Routzahn, K. M.; Copeland, T. D.; Waugh, D. S.
  3. Acta Crystallographica.Section D, Biological Crystallography. 2001 57(Pt 6): 793-799.
  1. 16.   Presence of potential nickel-responsive element(s) in the mouse MTH1 promoter
  2. Liang, R.; Igarashi, H.; Tsuzuki, T.; Nakabeppu, Y.; Sekiguchi, M.; Kasprzak, K. S.; Shiao, Y. H.
  3. Annals of Clinical and Laboratory Science. 2001 31(1): 91-98.
  1. 17.   Homology modeling and molecular dynamics simulations of lymphotactin
  2. Buyong, Xiong J.; Lubkowski, J.; Nussinov, R.
  3. Protein Science. 2000 9(11): 2192-2199.
  1. 18.   Mass spectrometry as a tool for studying the action of human aspartic proteases on peptides and proteins
  2. Tarasova, N. I.; Czerwinski, G.; Roberts, N. B.; Lubkowski, J.; Sumpter, T. L.; Green, B. N.; Michejda, C. J.; James, M. N. G.
  3. Aspartic Proteinases: Retroviral and Cellular Enzymes. 1998; 436 : 201-206.
  1. 19.   Mouse Annexin Iii Cdna, Genetic Mapping and Evolution
  2. Fernandez, M. P.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Morgan, R. O.
  3. Gene. 1998 207(1): 43-51.
  1. 20.   Cellular apoptosis susceptibility gene capts maps to mouse chromosome 2
  2. de Miguel, M.; Centanni, J. M.; Gopalan, G.; Gilbert, D. J.; Copeland, N. G.; Jenkins, N. A.; Donovan, P. J.
  3. Mammalian Genome. 1998 9(5): 411-412.
  1. 21.   Structural analysis of plasmepsin II. A comparison with human aspartic proteases
  2. Silva, A. M.; Lee, A. Y.; Erickson, J. W.; Goldberg, D. E.
  3. Advances in Experimental Medicine and Biology. 1998 436: 363-373.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel